Dichotomous effect of a traditional Japanese medicine, Bu-zhong-yi-qi-tang on allergic asthma in mice

被引:41
作者
Ishimitsu, R
Nishimura, H
Kawauchi, H
Kawakita, T
Yoshikai, Y [1 ]
机构
[1] Nagoya Univ, Sch Med, Res Inst Dis Mechanism & Control, Lab Host Def & Germfree Life, Nagoya, Aichi 4668550, Japan
[2] Shimane Med Univ, Dept Otorhinolaryngol, Izumo, Shimane 6938551, Japan
[3] Kanebo Ltd, Kampo Tradit Japanese Med Res Labs, Tokyo, Japan
关键词
Bu-zhong-yi-qi-tang; Th1/Th2; differentiation; asthma;
D O I
10.1016/S1567-5769(01)00022-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To determine the potentiality of prophylactic and/or therapeutic approaches using a traditional herbal medicine, Bu-zhong-yi-qi-tang (Japanese name: Hochu-ekki-to. HOT), for the control of allergic disease, we examined the effects of oral administration of HOT on a murine model of asthma allergic responses. When oral administration of HOT was begun at the induction phase immediately after OVA sensitization. eosinophilia and Th2-type cytokine production in the airway were reduced in OVA-sensitized mice following OVA inhalation. The serum levels of OVA-specific immunoglobulin (Ig)E and IgG(1) were significantly decreased, whereas the level of OVA-specific IgG(1), was increased, Interleukin (IL)-4 production by spleen T cells in response to OVA was significantly suppressed, while Interferon (IFN)-gamma production was increased in mice treated with HOT in the induction phase. On the other hand, HOT given in the eliciting phase induced a predominant Th2 response with increased IgE production in OVA-sensitized mice following OVA inhalation. These results suggest that the oral administration of HOT dichotomously modulates allergic inflammation in a murine model for asthma, thus offering a different approach for the treatment of allergic disorders. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:857 / 865
页数:9
相关论文
共 28 条
[1]   Decreased prevalence of atopy in rheumatoid arthritis [J].
Allanore, Y ;
Hilliquin, P ;
Coste, J ;
Renoux, M ;
Menkès, CJ .
LANCET, 1998, 351 (9101) :497-497
[2]   Early BCG vaccination and development of atopy [J].
Alm, JS ;
Lilja, G ;
Pershagen, G ;
Scheynius, A .
LANCET, 1997, 350 (9075) :400-403
[3]  
Barnes PJ, 1998, PHARMACOL REV, V50, P515
[4]   SERUM LEVELS OF INTERLEUKIN-4, SOLUBLE CD23 AND IFN-GAMMA IN RELATION TO THE DEVELOPMENT OF ALLERGIC DISEASE DURING THE FIRST 18 MONTHS OF LIFE [J].
BORRES, MP ;
EINARSSON, R ;
BJORKSTEN, B .
CLINICAL AND EXPERIMENTAL ALLERGY, 1995, 25 (06) :543-548
[5]   Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: Inhibition by a non-anaphylactogenic anti-IgE antibody [J].
Coyle, AJ ;
Wagner, K ;
Bertrand, C ;
Tsuyuki, S ;
Bews, J ;
Heusser, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1303-1310
[6]  
GAJEWSKI TF, 1989, J IMMUNOL, V143, P15
[7]   MAST-CELL-LEUKOCYTE CYTOKINE CASCADES IN ALLERGIC INFLAMMATION [J].
GALLI, SJ ;
COSTA, JJ .
ALLERGY, 1995, 50 (11) :851-862
[8]  
García VE, 1998, J IMMUNOL, V160, P4322
[9]   Development of eosinophilic airway inflammation and airway hyperresponsiveness requires interleutkin-5 but not immunoglobulin E or B lymphocytes [J].
Hamelmann, E ;
Takeda, K ;
Schwarze, J ;
Vella, AT ;
Irvin, CG ;
Gelfand, EW .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1999, 21 (04) :480-489
[10]   Role of IgE in the development of allergic airway inflammation and airway hyperresponsiveness - a murine model. [J].
Hamelmann, E ;
Tadeda, K ;
Oshiba, A ;
Gelfand, EW .
ALLERGY, 1999, 54 (04) :297-305